Journal Articles | October 2019

Prioritising the most needed paediatric antiretroviral formulations

The PADO4 list
Download Resource:
Download (Article)

Overview

The World Health Organization-led Paediatric Antiretroviral Drug Optimization (PADO) group establishes and reviews priorities for drug development, and set the foundation for GAP-f in the areas of paediatric HIV treatment and prevention. This consortium’s latest development included how to overcome barriers to newer, optimized pediatric ARV formulations for immediate and widely-accessed use in countries with high HIV burden.

Topics:

Pediatric HIV Diagnosis, Care & Treatment; Strategic Information, Evaluation & Research

Explore Other Resources

Journal Articles Follow-Up Outcomes of Children, Adolescents, and Young People on Darunavir-Based Third-Line Antiretroviral Therapy Observational Cohort From 9 African Countries Adolescent Identification, Care & Treatment; Pediatric HIV Diagnosis, Care & Treatment
Issue Briefs Building a Future of Health Leading the Fight to End AIDS and TB in Children Pediatric HIV Diagnosis, Care & Treatment; Tuberculosis
Little girl's hands Issue Briefs Building Trust for Global Health Accelerating Access to Lifesaving Medicines for Children HIV Treatment Optimization; Pediatric HIV Diagnosis, Care & Treatment
All Resources